New but controversial ALS drug, Relyviro, approved by FDA

Bio-Rad and Qiagen plan to merge in a deal potentially worth over $10bn

FDA approves AstraZeneca's liver cancer treatment

FDA approves Furosemide to treat patients with chronic heart failure

New cancer vaccine may be available by 2030

Johnson & Johnson is planning to acquire Abiomed for $17bn

Gilead Sciences and Macrogenics partner for bispecific antibody development

FDA recalls two blood pressure pills due to risk that they may cause cancer

FDA approves GSK's whooping cough vaccine, Boostrix, for use in pregnant patients

New pill which may halt cancer is given to first patient in a trial

Aaron Bean at Veeva explores the challenges of rare diseases: With up to 30 million people in EU living with rare diseases, Veeva discusses the challenges facing these rare diseases

Pharmafile Events 2022-2023